-
Je něco špatně v tomto záznamu ?
Morbidity through 3 Years of Age in Children of Women Using Methamphetamine during Pregnancy: A National Registry Study
R. Gabrhelík, S. Skurtveit, B. Nechanská, V. Mravčík, M. Handal
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
PubMed
36423599
DOI
10.1159/000527238
Knihovny.cz E-zdroje
- MeSH
- dítě MeSH
- kohortové studie MeSH
- lidé MeSH
- methamfetamin * škodlivé účinky MeSH
- morbidita MeSH
- opioidní analgetika terapeutické užití MeSH
- poruchy spojené s užíváním opiátů * epidemiologie farmakoterapie MeSH
- registrace MeSH
- těhotenství MeSH
- zpožděný efekt prenatální expozice * epidemiologie MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: There is a lack of studies on methamphetamine (MA) exposure and morbidity in children beyond the perinatal period. OBJECTIVES: We compared morbidity in children (0-3 years) with prenatal MA exposure to opioid-exposed and to non-exposed children. METHODS: We used data from a Czech nationwide, registry-based cohort study (2000-2014). Children, who reached 3 years of age, of mothers hospitalized with (i) MA use disorder during pregnancy (MA; n = 194), (ii) opioid use disorder during pregnancy (opioids; n = 166), and (iii) general population (GP; n = 1,294,349) with no recorded history of substance use disorder (SUD). Information on inpatient contacts, length of stay, and diagnoses (International Statistical Classification of Diseases and Related Health Problems 10th Revision [ICD-10]) were assessed. Crude and adjusted odds ratios (aOR), 95% confidence interval (CI) for the risk of hospitalization, and for getting diagnosis from the ICD-10 diagnosis chapters were calculated using binary logistic regression. A stratified analysis on hospitalizations with SUD of mothers was performed. RESULTS: No significant differences were found in the measures of hospitalization between the MA and opioid groups. Children prenatally exposed to MA and opioids had higher numbers of hospitalizations and diagnoses and longer stays in hospital than children in the GP. Increased risks of certain infectious and parasitic diseases were found in both MA (aOR = 1.6; CI: 1.1-2.3) and opioid (aOR = 1.9; 1.3-2.8) groups as compared to the GP group. The most pronounced difference in stratified analysis on maternal hospitalizations related to SUD after birth was observed for injury, poisoning, and certain other consequences of external causes in the strata of the MA group who had hospitalized mothers (aOR 6.3, 1.6-24.6) compared to the strata without maternal hospitalizations (aOR 1.4, 0.9-2.3). CONCLUSION: This study suggests that children born to mothers using MA during pregnancy have similar morbidity during the first 3 years of life but higher than the GP. The excess of risk was primarily due to infections and injuries in the MA group.
Department of Addictology 1st Faculty of Medicine Charles University Prague Czechia
Department of Addictology General University Hospital Prague Prague Czechia
Norwegian Centre for Addiction Research at the University of Oslo Oslo Norway
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004753
- 003
- CZ-PrNML
- 005
- 20230425171713.0
- 007
- ta
- 008
- 230418s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000527238 $2 doi
- 035 __
- $a (PubMed)36423599
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Gabrhelík, Roman $u Department of Addictology, First Faculty of Medicine, Charles University, Prague, Czechia $u Department of Addictology, General University Hospital in Prague, Prague, Czechia
- 245 10
- $a Morbidity through 3 Years of Age in Children of Women Using Methamphetamine during Pregnancy: A National Registry Study / $c R. Gabrhelík, S. Skurtveit, B. Nechanská, V. Mravčík, M. Handal
- 520 9_
- $a BACKGROUND: There is a lack of studies on methamphetamine (MA) exposure and morbidity in children beyond the perinatal period. OBJECTIVES: We compared morbidity in children (0-3 years) with prenatal MA exposure to opioid-exposed and to non-exposed children. METHODS: We used data from a Czech nationwide, registry-based cohort study (2000-2014). Children, who reached 3 years of age, of mothers hospitalized with (i) MA use disorder during pregnancy (MA; n = 194), (ii) opioid use disorder during pregnancy (opioids; n = 166), and (iii) general population (GP; n = 1,294,349) with no recorded history of substance use disorder (SUD). Information on inpatient contacts, length of stay, and diagnoses (International Statistical Classification of Diseases and Related Health Problems 10th Revision [ICD-10]) were assessed. Crude and adjusted odds ratios (aOR), 95% confidence interval (CI) for the risk of hospitalization, and for getting diagnosis from the ICD-10 diagnosis chapters were calculated using binary logistic regression. A stratified analysis on hospitalizations with SUD of mothers was performed. RESULTS: No significant differences were found in the measures of hospitalization between the MA and opioid groups. Children prenatally exposed to MA and opioids had higher numbers of hospitalizations and diagnoses and longer stays in hospital than children in the GP. Increased risks of certain infectious and parasitic diseases were found in both MA (aOR = 1.6; CI: 1.1-2.3) and opioid (aOR = 1.9; 1.3-2.8) groups as compared to the GP group. The most pronounced difference in stratified analysis on maternal hospitalizations related to SUD after birth was observed for injury, poisoning, and certain other consequences of external causes in the strata of the MA group who had hospitalized mothers (aOR 6.3, 1.6-24.6) compared to the strata without maternal hospitalizations (aOR 1.4, 0.9-2.3). CONCLUSION: This study suggests that children born to mothers using MA during pregnancy have similar morbidity during the first 3 years of life but higher than the GP. The excess of risk was primarily due to infections and injuries in the MA group.
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a methamfetamin $x škodlivé účinky $7 D008694
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a opioidní analgetika $x terapeutické užití $7 D000701
- 650 12
- $a zpožděný efekt prenatální expozice $x epidemiologie $7 D011297
- 650 _2
- $a registrace $7 D012042
- 650 12
- $a poruchy spojené s užíváním opiátů $x epidemiologie $x farmakoterapie $7 D009293
- 650 _2
- $a morbidita $7 D009017
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Skurtveit, Svetlana $u Norwegian Institute of Public Health, Oslo, Norway $u Norwegian Centre for Addiction Research at the University of Oslo, Oslo, Norway
- 700 1_
- $a Nechanská, Blanka $u Department of Addictology, First Faculty of Medicine, Charles University, Prague, Czechia
- 700 1_
- $a Mravčík, Viktor $u Department of Addictology, First Faculty of Medicine, Charles University, Prague, Czechia
- 700 1_
- $a Handal, Marte $u Department of Addictology, First Faculty of Medicine, Charles University, Prague, Czechia $u Norwegian Institute of Public Health, Oslo, Norway
- 773 0_
- $w MED00007942 $t European addiction research $x 1421-9891 $g Roč. 29, č. 1 (2023), s. 19-29
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36423599 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425171710 $b ABA008
- 999 __
- $a ok $b bmc $g 1925069 $s 1190962
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 29 $c 1 $d 19-29 $e 20221124 $i 1421-9891 $m European addiction research $n Eur Addict Res $x MED00007942
- LZP __
- $a Pubmed-20230418